Objective: Surgical site infection (SSI) after open lower extremity bypass (LEB) is a serious complication leading to an increased rate of graft failure, hospital readmission, and health care costs. This study sought to identify predictors of SSI after LEB for arterial occlusive disease and also potential modifiable factors to improve outcomes.
Purpose or Statement of Need The purpose of this journal-based CME activity is to enhance the vascular specialist's ability to diagnose and care for patients with the entire spectrum of circulatory disease through a comprehensive review of contemporary vascular surgical and endovascular literature. Learning Objectives At the end of this activity, participants should be able to: Editors and Reviewer Disclosure Information JVS Editors (editors, associate editors, assistant editors) have no relevant financial relationships to disclose per the Society for Vascular Surgery policy that requires JVS Editors have no direct financial relationships with industry during their terms of service. The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest. Instructions on Participation and Receiving Credit The CME Program is free for journal subscribers. Nonsubscribers will be required to pay $10 per exam certificate. This activity is designed to be completed within one hour; physicians should claim only those credits that reflect the time actually spent in the activity.
To successfully earn credit, participants must complete the activity online during the valid period. One year from the release date, tests will expire and credit will no longer be offered.
Results: Our study population included 3033 patients who underwent 703 femoral-femoral bypasses, 1431 femoralpopliteal bypasses, and 899 femoral-distal vessel bypasses. An SSI was diagnosed in 320 patients (10.6%) #30 days after the index operation. Adjusted patient and procedural predictors of SSI included renal failure currently requiring dialysis (OR, 4 . SSI resulted in increased risk of major amputation and surgical reoperation (P < .01), but did not affect 30-day mortality.
Conclusions: SSI after LEB is associated with an increase in rate of amputation and reoperation. Several patient, operative, and hospital-related risk factors that predict postoperative SSI were identified, suggesting that targeted improvements in perioperative care may decrease complications and improve vascular patient outcomes. (J Vasc Surg 2017;65:1769-78.)
Surgical site infection (SSI) is one of the most common postoperative complications after vascular reconstruction, particularly lower extremity bypass (LEB) procedures. 1 This complication produces significant morbidity and can result in increased length of stay, hospital readmission, graft failure, and limb loss. [2] [3] [4] The published incidence of SSI after LEB has varied from 4.8% 5 to
22.8%, 6 with different rates reported based on the evaluated data set. Prior studies have identified a number of clinical variables that are directly related to the incidence of SSI. Reported patient-related factors include female gender, 3, 7 advanced age, 1 obesity, 8 dialysis dependence, 3 and diabetes. 9 More recently, perioperative variables, including blood transfusion and operative duration, have been linked to SSI after LEB. 5 These studies used large registry data sets from multiple hospitals but did not examine structural or process-of-care characteristics of the hospitals where the procedures were performed. The American College of Surgeons National Surgical Quality Improvement Program Best Practices Initiative recently concluded that hospital-level structural and process-of-care characteristics can have a significant effect on the overall rates of SSI after general surgery procedures. 10 To decrease the incidence of SSI, identifying process measures that link directly to SSI outcomes is important because many process measures are portable and could be implemented across health care systems. This study used a large statewide vascular surgical quality registry to determine the predictors of SSI after LEB. We sought to identify independent patient preoperative and operative risk factors and to determine whether hospital structural or process-of-care characteristics are predictive risk factors for SSI.
METHODS
Patient selection. The Blue Cross Blue Shield of Michigan Cardiovascular Consortium Vascular Intervention Collaborative (BMC2 VIC) was the data source for this study. BMC2 VIC is a prospective, multicenter, observational registry designed to collect information on patients undergoing vascular surgical procedures in an effort to evaluate outcomes and to improve quality. . Due to database constraints, the "first" documented procedure for a given patient within the BMC2 VIC may not have been the first vascular intervention the patient underwent because we do not have procedural-specific information for patients who underwent operations before the creation of the BMC2 VIC in 2012 or had several procedures between 2012 and 2015 at hospitals that were not included in our registry. To avoid violations of independence in the statistical analysis, a single procedure was randomly selected for each of the 446 patients with multiple LEB procedures, resulting in 3033 LEB individual patients and procedures being included in the analysis. A data form was compiled for each patient, including demographic information, medical history, standard blood and chemistry laboratory test results before and after the procedure, procedural indications (claudication, critical limb ischemia, and acute limb ischemia) and types (suprainguinal and infrainguinal), procedural urgency, technical details of procedures, and associated complications, if they occurred. Of note, the BMC2 VIC does not collect the following information: weight loss before surgery, prealbumin, negative wound pressure therapy, Szilagyi grade of infections, or active chemotherapy at the time of the operation.
Information was collected on preoperative medications, including antiplatelet (aspirin, clopidogrel, prasugrel, and ticagrelor), angiotensin-converting enzyme inhibitor, statin, and b-blocker. Information was not collected on anticoagulation medications, including warfarin and novel anticoagulants, or the specific antibiotics used intraoperatively because this varied according to hospital-specific guidelines for antibiotic surgical prophylaxis.
Coronary artery disease was defined as a history of myocardial infarction, percutaneous coronary intervention, or coronary artery bypass graft. Cerebrovascular disease was defined as a history of stroke or transient ischemic attack. SSI was defined as patients being diagnosed with a wound site or graft infection, with or without sepsis, before discharge, or as readmission for a wound or graft infection or dehiscence, or both.
Outcome. The primary outcome included the development of an SSI #30 days from the index operation. The secondary outcome was the patient morbidity and mortality rate associated with SSI occurrence. Data quality and the inclusion of consecutive procedures are ensured by ad hoc queries, random medical record review, and a series of diagnostic routines included in the database conducted by the coordinating center. Sites are audited twice yearly by a nurse monitor from the coordinating center. All cases associated with severe complications and a randomly selected 5% of cases are audited for accuracy.
Statistical analysis. Patients were categorized as those with or without SSI and their demographic, clinical history, and procedural variables were compared by generating frequencies and percentages for categoric variables and means and standard deviations for continuous variables across groups. In each descriptive analysis, unadjusted comparisons included c 2 tests for categoric variables and two-tailed t-tests for continuous variables.
Previous studies relied on parametric logistic regression models to identify independent risk factors of SSI, but this approach has problems because the low incidence of SSI makes it difficult to use all patient, procedural, and hospital factors that may affect the occurrence of SSI. Regression models that attempt to use all factors are often overfitted, meaning the model describes random noise rather than the underlying relationships between the variables, 13 and traditional methods of factor selection tend to produce biased effect estimates. 14 Machine learning algorithms that can discover complex relationships among a large number of risk factors have recently been used. 15 In this study we used the Super Super Learner is a method of selecting the optimal weighted combination of a set of candidate prediction algorithms through cross validation. 16 An assortment of candidate prediction algorithms were fashioned using SSI as the outcome and all factors as predictors (except one very common factor of no preprocedure antibiotics and two very rare factors of intraoperative myocardial infarction and cardiac arrest, which were excluded to avoid violations of the positivity assumption). The algorithms are trained and then validated using cross-validation to identify a weighted combination of algorithms that provides the smallest squared prediction error, which was then used as the initial TMLE estimate of each factor's effect on the occurrence of SSI. TMLE is a two-part estimation procedure that, for each factor, first estimates the probability of SSI given exposure to the factor and covariates, and then uses the probability of exposure to the factor given covariates (a propensity score) to update the initial estimate in a step that "targets" the optimal bias-variance trade-off for that factors effect on SSI. 17 The LASSO (least absolute shrinkage and selection operator) penalized regression algorithm was used to generate the propensity score. The TMLE approach has two advantages: First, it incorporates machine learning so the limitations of parametric methods are avoided, and second, it is "double robust," meaning that estimates are asymptotically unbiased if the initial estimate or the propensity score is correctly specified. 18 Subgroup analysis by hospital was not done for two reasons. First, some of our hospitals were quite small and had low rates of SSI that would likely violate the positivity assumption. Second, we were interested in identifying hospital structural or process-of-care characteristics that were predictive of SSI, controlling for individual level factors.
To understand how SSI affects other 30-day morbidity and mortality outcomes, frequencies and percentages were calculated across LEB procedure for patients with and without SSI for each secondary outcome, and Procedural length, peak intraoperative glucose, and iodine-based skin preparation increased the risk.
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d Recommendation: The authors recommend using noniodine-based skin preparation, controlling intraoperative glucose levels, and decreasing procedural length to reduce the risk for surgical site infection.
permutation tests were calculated to account for multiple comparisons. Although missing data were limited (6% average across all variables), the rate of missing data for some factors was substantial, so k nearest neighbor imputation was used to singly impute missing values for all factors because this approach works well with machine learning algorithms. 19 A limited sensitivity analysis was conducted which deemed imputed analysis was the most appropriate. All calculations were performed with R 3.0.2 statistical software (The R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Patient characteristics. The study population consisted of 3033 patients (31% women) who underwent open LEB. The average age was 66 (standard deviation, 10.5) years. Approximately, 83% of the study population were white, and 17% were black or of another race. A minority of patients had undergone previous vascular surgical procedures. Vascular-related comorbidities were highly prevalent across the study population, including hypertension (89%), hyperlipidemia (84%), diabetes (42%), coronary artery disease (51%), and chronic obstructive pulmonary disease (36%). Many patients were overweight or obese (65%), and 44.9% were current smokers (Table I) .
Of the 3033 patients who underwent open LEB, 320 (10.6%) were identified as having an SSI #30 days of the index operation (Table I) . Patients who developed SSIs had a greater body mass index (BMI) but no difference in mean age or smoking status. Overall, patients who had an SSI had a higher comorbid disease burden compared with patients who did not have a postoperative SSI. Of note, patients who developed SSIs were more likely to have severe symptoms on the Peripheral Artery Questionnaire (PAQ) Score, present with rest pain, or have an ankle-brachial index of <0.35 before their index operation. There was a high adherence to cardioprotective medications across the cohort preoperatively (Supplementary Table II , online only).
The indications for the procedure included one or more of the following: claudication (72.0%), rest pain (50.5%), ulcer/gangrene (32.4%), or acute limb ischemia (15.1%). Regarding operative characteristics, preoperative antibiotics were appropriately administered in 97% of patients, demonstrating high compliance across the BMC2 VIC (Table II) . Bivariate analysis showed surgery type was associated with SSI, with infrainguinal procedures more commonly experiencing SSI postoperatively. For intraoperative events, the need for blood transfusion, prolonged procedural time, and high intraoperative glucose levels were all associated with an increased rate of SSI.
Structural and processes-of-care characteristics of hospitals within the cohort. Prior investigations have demonstrated that hospital structural and processesof-care characteristics can profoundly affect the rate of SSI. 10 Variations of hospital characteristics were therefore analyzed within our cohort (Table III) . A large variation was found in hospital size (quantified by number of hospital beds), annual LEB operative volume, and the number of medical trainees across the hospitals, which contributed to the quality collaborative.
Independent predictors of SSI. The final Super Learner prediction model containing patient, procedure, and hospital factors had a cross-validated area under the receiver operating characteristic curve value of 0.692, indicating that the model is fair at discriminating between patients with and without SSI. A complete description of the development of the Super Learner prediction model can be found in the Appendix (online only).
The TMLE estimates of the patient, procedural, and hospital processes of care, independent factors that have significant relationship with SSI, are listed in Table IV (TMLE estimates of all factors are listed in  Supplementary Table III , online only). In agreement with previous studies, obesity 8 Association between SSI and 30-day morbidity and mortality. Patients with an SSI were at an increased risk of several postoperative morbidities, including postoperative transfusion, lymph leak, major amputation, and open surgical bypass revision #30 days of the index operation (P < .05; Table V) . SSI was not associated with a difference in 30-day mortality.
DISCUSSION
SSI is one of the most common postoperative complications after LEB procedures. 1 Compared with other major vascular surgery procedures, the development of an SSI after LEB occurs at a 3.1-fold higher rate than after abdominal aortic aneurysm repair and w15-fold higher than after carotid endarectomy. 8, 20 This complication produces significant morbidity and can result in increased length of stay, hospital readmission, graft failure, and limb loss. 21 Prior studies have identified a number of clinical variables that are directly related to the incidence of SSI. However, few studies have investigated the hospital structural and process-of-care characteristics that may contribute to SSI after LEB. We demonstrate, using a large statewide cardiovascular consortium, a 10.6% incidence of SSI after LEB, which is comparable to other contemporary studies demonstrating an SSI rate of 4.8% to 17.0%. 3, 5, 8, 22 The risk of SSI was increased by a number of independent patient variables (BMI >25 kg/m 2 , hypertension, chronic renal failure requiring dialysis, prior vascular surgery, use of antiplatelet medication, and PAQ score) as well as procedural variables (procedural length, intraoperative thrombosis, skin preparation, and peak glucose). Although many of these identified risk factors are not modifiable, others represent potential avenues for quality improvement to reduce the rate of SSI.
Prior investigations have noted association between SSI after LEB and patient factors of dialysis dependence, 23, 24 obesity, 1,25 and hypertension. 3, 4 The association between end-stage renal disease requiring dialysis and increased risk for infection likely arises from the underlying uremia that has been shown to depress the immune system. The function of polymorphonuclear white blood cells, lymphocytes, and monocytes is altered in these patients, resulting in an impaired host response to infection. [26] [27] [28] Further, patients undergoing chronic hemodialysis may have higher rates of colonization by potential pathogens. 29 For overweight or obese patients, greater thickness of poorly vascularized subcutaneous fat, combined with increased bacterial density in groin creases, may account in part for the increased incidence of SSI. Within our current study, unique patient factors associated with SSI after LEB included PAQ symptom severity score, prior vascular surgery, and use of antiplatelet medication. PAQ symptom severity and prior vascular surgery are likely markers of the severity of vascular disease, with poor peripheral and subcutaneous vascularization leading to delayed wound healing and an opportunity for microbial proliferation. In addition, it has been previously been noted that revision procedures can increase the risk of SSI across surgical specialties. 30, 31 Surprisingly, preoperative antiplatelet medication was found to be a risk factor for SSI. The effect of antiplatelet medication on postoperative SSI has not previously been explored in the vascular surgery literature, while other surgical fields have demonstrated conflicting results. 32, 33 As expected, a high percentage of patients (78.7%) were taking antiplatelet medications at the time of their LEB. Antiplatelet medication can increase the risk of bleeding, transfusion, and reoperation. However, the association of antiplatelet medication with SSI within this study was independent of the need for operative transfusion, postoperative nadir hemoglobin <10 mg/dL, or the need for repeat intervention. Another explanation for the observed increased risk of SSI in patients taking antiplatelet medication relates to the role of platelets in innate and adaptive immunity. 34 Prior investigations have demonstrated that activated platelets express P-selectin, which serves as a receptor for recruitment of neutrophils and monocytes via engagement of P-selectin glycoprotein ligand 1. 35 The interaction of P-selectin on activated platelets with leukocyte P-selectin glycoprotein ligand 1 in turn stimulates neutrophils and monocytes to release proteolytic granules and cytokines that augment the immune response. 36, 37 Platelet-leukocyte interactions are associated with an enhanced inflammatory response, improved phagocytosis of bacteria, 38 and augmentation of neutrophil extracellular trap formation. 39 By inhibiting platelet activation, all antiplatelet agents have the theoretical potential to diminish these activation-dependent platelet immune functions. Clinical rates of infection, particularly pneumonia, have been found to be significantly higher in patients taking clopidogrel. 40 Additional work is needed to confirm these observations and to determine the effect of antiplatelet therapy on host immunity in the clinical setting. 30, 31 At the procedural level, similar to prior investigations, this study noted an association between prolonged operative time and SSI after LEB. 10 We also found an increased risk of SSI in patients who were hyperglycemic (peak glucose >180 mg/dL) intraoperatively. The American Diabetes Association and the American Association of Clinical Endocrinologists currently recommend maintaining random serum glucose values of #180 mg/dL in the perioperative period for all noncardiovascular surgical procedures. 42 Diabetes has been demonstrated as a risk factor for SSI. 8, 43 Within our study, however, peak glucose >180 mg/dL was a greater risk factor than preoperative diabetes as a medical comorbidity, perhaps because intraoperative glucose levels more accurately reflect the level of diabetic control at the time of the operative intervention. Increased infection associated with hyperglycemia can be partially attributed to physiologic alterations precipitated by inadequate glucose control. Persistent hyperglycemia results in impairment of neutrophil chemotaxis, phagocytosis, and adherence as well as glycosylation of collagen matrix proteins, which can contribute to weakened antibacterial defenses and to delayed wound healing. 44, 45 Although a recent meta-analysis of five randomized controlled trials of general surgery patients found insufficient evidence to support strict glycemic control (glucose level <200 mg/dL) over conventional management for the prevention of SSI, it is possible that cardiovascular surgery patients represent a specific surgical subgroup that benefits from glycemic control. 46 Indeed, the adverse effect of perioperative hyperglycemia on the incidence of SSI is well documented in patients undergoing cardiac surgery. 47 Similarly, in a retrospective study of patients undergoing infrainguinal vascular surgery, Vriesendorp et al 48 found that hyperglycemia was associated with increased postoperative infections. Numerous preoperative and intraoperative precautions are taken in an attempt to prevent SSI, including preoperative showering/bathing, 49 preincisonal antibiotics, and localized skin antiseptic. 50 In the current study, preoperative antibiotics were appropriately administered in 97% of cases, demonstrating high compliance across the BMC2 VIC. Interestingly, despite this high compliance, localized skin preparation with iodine only was used in 12% of patients instead of chlorhexidine and found to be significantly associated with SSI. Chlorhexidinealcohol was recently compared with povidone iodine in a six-center randomized trial of 849 patients across different surgical specialties. 50 This trial demonstrated a reduction of SSI from 16.1% to 9.5% with the use of chlorhexidine-alcohol over other localized skin antisepsis (relative risk, 0.59; 95% CI, 0.41-0.85; P ¼ .004). Orthopedic and gynecologic clinical trials have also noted a reduction in SSI after use of chlorhexidine-alcohol. 51, 52 Despite the absence of vascular surgery procedures in the above trials, chlorhexidine-alcohol preparation has also been shown to reduce the risk of SSI after vascular surgery. 5 Although iodine and chlorhexidine-alcohol both provide broad-spectrum antimicrobial activity, the superior clinical protection of chlorhexidine-alcohol is likely related to its more rapid action as well as persistent activity despite exposure to bodily fluids. Unlike patient preoperative risk factors, the use of iodine skin antiseptic is a modifiable risk factor for SSI, and continued emphasis should be made to reduce the use of iodine-only antiseptics.
At the hospital and process-of-care level, our study demonstrates a high risk of SSI in hospitals involved with the training of young physicians. An adverse effect of "teaching hospital" status was previously noted in the Veterans Affairs Hospital system with respect to surgical morbidity as well as in the National Surgical Quality Improvement Program database when SSI was analyzed across an array of general surgery procedures. 10, 53 As shown in this study and others, the longer a wound is open the higher risk of SSI. However, the increased risk of SSI at a teaching hospital demonstrated within this study was independent of operative duration. Indeed, teaching a trainee to operate can be a lengthy process; however, differences in the structure and process of care between teaching and nonteaching hospitals may also be a cause for the increased morbidity rates in teaching hospitals. Teaching hospitals are typically larger and more complex than nonteaching hospitals, with greater turnover as all staff rotate through the affiliated teaching institutions. These more complex systems of care and constantly changing attendings and residents may create conditions in which complications, particularly infections, can occur more frequently. Of the 70 potential risk factors used in the TMLE analysis, only 16 risk factors were statistically significant independent risk factors of SSI. This is much fewer than what was found in the bivariate analysis summarized in Tables I-III , as TMLE accounts for the interrelationships among the other risk factors, similar to multivariable logistic regression. The advantage of TMLE is its robustness to accurately account for misspecification often found with analyzing rare outcomes. 18 Ultimately, the predictive modeling of SSI after LEB has several important applications, including quality assessment as well as accurately conveying a more individualized risk to patients, depending on the patient's preoperative medical comorbidities. At this time we do not believe vascular surgeons should alter their surgical approach if the patient is a high risk for SSI because, ultimately, a quality bypass with the longest patency is of the utmost importance to the overall health of a patient. Limitations of the current study include its observational and retrospective nature as opposed to a randomized trial. The database was developed as a quality improvement tool to compare institutions' individual outcomes with a statewide benchmarking. As such, the database is not entirely comprehensive with every patient characteristic, intraoperative variable, and postoperative occurrence possible in regards to LEB revascularization. For example, lower extremity ulceration was not associated with an increased risk of SSI, perhaps due to limitations in distinguishing between wet and dry gangrene at the time of operative intervention. We cannot account for all potential confounders that were outside of the study design, such as intraoperative anesthetic and fluid management, technical skill of the surgeon, and critical care management postoperatively, despite rigorous standardized prospective collection and assessment of data and statistical adjustments. As a result, it is possible that some of the statistically significant associations with measured factors found in this study are spurious and the result of an unmeasured confounder that is associated with both a measured factor and the outcome SSI.
In addition, the outcomes assessed are limited to 30-day events. Wound complications generally occur within this period; however, they may develop beyond this time and would not be counted. Long-term graft failure and mortality are factors that we are unable to analyze.
Finally, the results may not be generalizable outside of the state of Michigan because of the differences in hospital characteristics, surgical practice, or access to relevant resources. However, the mix of academic, private, and community hospitals within this study represents the pragmatic, real-world experience.
CONCLUSIONS
In this study, we used a large statewide cardiovascular consortium to demonstrate an incidence of SSI of 10.6% after LEB. The risk of SSI was increased by independent patient (BMI >25 kg/m 2 , hypertension, chronic renal failure requiring dialysis, use of antiplatelet medication, prior vascular surgery, PAQ score), procedural (operative length, antiseptic skin preparation, and peak glucose), and hospital variables (hospital size and involvement with teaching). Although some factors, such as patient comorbidities, are not modifiable, others represent areas of target for quality improvement for at risk patients. Notably, diligence should be devoted to decreasing operative length, controlling intraoperative glucose levels, and avoiding iodine-only skin preparation to decrease the rate of SSIs and its numerous associated morbidities in vascular surgery patients.
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